M&A Deal Summary

ICON Acquires PRA Health Sciences

On February 24, 2021, ICON acquired life science company PRA Health Sciences for 12.0B USD

Acquisition Highlights
  • This is ICON’s 16th transaction in the Life Science sector.
  • This is ICON’s largest (disclosed) transaction.
  • This is ICON’s 18th transaction in the United States.
  • This is ICON’s 2nd transaction in North Carolina.

M&A Deal Summary
Date 2021-02-24
Target PRA Health Sciences
Sector Life Science
Buyer(s) ICON
Deal Type Add-on Acquisition
Deal Value 12.0B USD
Advisor(s) UBS Investment Bank (Financial)
Paul, Weiss, Rifkind, Wharton & Garrison (Legal)

Target

PRA Health Sciences

Raleigh, North Carolina, United States
PRA Health Sciences' corporate headquarters in Raleigh, North Carolina.
PRA Health Sciences' corporate headquarters in Raleigh, North Carolina.
PRA Health Sciences, Inc. is an international clinical research organization. PRA provides services on a contract basis to the pharmaceutical and biotechnology industries. Comprehensive services include the filing of Investigational New Drug (IND) and similar regulatory applications, management and implementation of Phase I through IV clinical trials, preparation and submission of New Drug Applications (NDAs), and post-marketing surveillance on an international basis. PRA was formed in 1976 and is based in Raleigh, North Carolina.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ICON

Dublin, Ireland
Category Company
Founded 1990
Sector Life Science
Employees41,100
Revenue 8.1B USD (2023)
DESCRIPTION

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The company specialises in the strategic development, management and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. ICON was founded in 1990 and is based in Dublin, Ireland.

DEAL STATS #
Overall 29 of 29
Sector (Life Science) 16 of 16
Type (Add-on Acquisition) 25 of 25
State (North Carolina) 2 of 2
Country (United States) 18 of 18
Year (2021) 1 of 1
Size (of disclosed) 1 of 9
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-02-19 MedPass International

Paris, France

MedPass International is a European medical device CRO and consultancy. MedPass International is based in Paris, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-01 ICON - ADDPLAN Software

Dublin, Ireland

ICON's ADDPLAN Software is a stand-alone software used to design, simulate, and analyze innovative adaptive clinical trials with functionality for all phases of clinical development.

Sell -
Mergr

Product

Company

Legal